Lidocaine HCl Injection recalled over sterility concerns
- Recall date
- August 15, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Fagron Compounding Services recalls Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th…
- Recall number
- D-0636-2024
- FDA classification
- Class II
- Brand / firm
- Fagron Compounding Services
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.
Get recall alerts
Free email alert whenever Fagron Compounding Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fagron Compounding Services